search
Back to results

Acupuncture for Functional Constipation in Older Adults

Primary Purpose

Constipation - Functional

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
acupuncture
sham acupuncture
Sponsored by
Shanghai University of Traditional Chinese Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Constipation - Functional

Eligibility Criteria

60 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Meet Rome IV Diagnostic Criteria for Constipation and TCM Diagnostic Criteria of constipation with yin deficiency syndrome;
  • No gender restriction, age 60-80;
  • FC that is classified as mild or moderate;
  • Have not used any medicine for constipation at least 2 weeks before treatment (except emergency treatment);
  • Have not participated in other medical clinical trials over the past one month;
  • Those who can understand various evaluation scales, complete the evaluation and cooperate with the completion of the planned course of treatment;
  • Sign the informed consent.

Exclusion Criteria:

  • Irritable bowel syndrome and constipation caused by tumors, inflammatory reactions, endocrine and metabolic diseases, and drugs;
  • Constipation caused by organic diseases;
  • Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system, infectious diseases, tumors, and mental diseases;
  • Those who voluntarily give up or cannot cooperate with treatment and observation due to various circumstances;
  • Patients with cognitive impairment or aphasia;
  • Those who take other drugs during treatment, which affect the efficacy and judgment (except emergency treatment).

Sites / Locations

  • Longhua HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Acupuncture group

Sham acupuncture group

Arm Description

Participants will receive acupuncture treatment at Zhao Hai(KI 6), Da Zhong(KI 4), Tai Xi(KI 3), Tian Shu(ST 25), and Shang Ju Xu(ST 37) bilaterally. Each treatment will last 30 minutes and participants will receive the treatment 3 times per week (every other day) for 8 weeks, 24 sessions in total. Follow-up time is week 4 and week 12 after treatment (ie, week 12 and week 20).

Participants will receive sham acupuncture treatment on bilateral sham Zhao Hai(KI 6), Da Zhong(KI 4), Tai Xi(KI 3), Tian Shu(ST 25), and Shang Ju Xu(ST 37) that match real acupuncture points. The duration of needle retention, treatment period, and follow-up in the control group is the same as that in the intervention group.

Outcomes

Primary Outcome Measures

The change in the mean number of CSBMs per week compared to baseline during the 8-week treatment period
Complete Spontaneous Bowel Movements (CSBMs) refers to the frequency of a bowel movement that occurred in the absence of laxatives or manipulation.

Secondary Outcome Measures

Bristol Stool Scale
A scale to classify the patient's voluntary bowel movement stool.
Patient Assessment of Constipation-Symptoms (PAC-SYM)
A scale to assess the condition of the patient's constipation-related symptoms
Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL)
A brief but comprehensive assessment of the daily life quality of patients with FC, containing 28 items
Self-rating Anxiety Scale(SAS)
A measure of somatic symptoms associated with anxiety reactions.
Self-rating Depression Scale(SDS)
A self-rating scale to assess patients' depression
Weekly usage of emergency bowel medications
The proportions of participants using medications and doses for emergency treatment
Incidence of adverse events
The adverse events (AEs) assessment aims at evaluating the AEs of acupuncture treatment.

Full Information

First Posted
August 9, 2022
Last Updated
October 25, 2022
Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Shanghai Municipal Hospital of Traditional Chinese Medicine, Longhua Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05496543
Brief Title
Acupuncture for Functional Constipation in Older Adults
Official Title
A Randomized Controlled Clinical Trial of Acupuncture in Nourishing Kidney and Dredging Fu Organs for Functional Constipation in Older Adults
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 10, 2022 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Shanghai Municipal Hospital of Traditional Chinese Medicine, Longhua Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Through a scientific and standardized randomized controlled study, we observe the effectiveness and safety of acupuncture in the treatment of functional constipation in the elderly through the method of "nourishing kidney and dredging Fu organs".
Detailed Description
Functional constipation is a common disease of old people. To date, there has not specific therapy on it. Former research showed acupuncture may work for functional constipation. In the trial, patients in the acupuncture and sham acupuncture groups will receive 24 acupuncture treatments over an 8-week period. This RCT is designed to confirm the efficacy and safety of acupuncture in functional constipation treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Constipation - Functional

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
84 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Acupuncture group
Arm Type
Experimental
Arm Description
Participants will receive acupuncture treatment at Zhao Hai(KI 6), Da Zhong(KI 4), Tai Xi(KI 3), Tian Shu(ST 25), and Shang Ju Xu(ST 37) bilaterally. Each treatment will last 30 minutes and participants will receive the treatment 3 times per week (every other day) for 8 weeks, 24 sessions in total. Follow-up time is week 4 and week 12 after treatment (ie, week 12 and week 20).
Arm Title
Sham acupuncture group
Arm Type
Placebo Comparator
Arm Description
Participants will receive sham acupuncture treatment on bilateral sham Zhao Hai(KI 6), Da Zhong(KI 4), Tai Xi(KI 3), Tian Shu(ST 25), and Shang Ju Xu(ST 37) that match real acupuncture points. The duration of needle retention, treatment period, and follow-up in the control group is the same as that in the intervention group.
Intervention Type
Device
Intervention Name(s)
acupuncture
Intervention Description
All acupoints will be routinely sterilized at first. After the insertion of the needles, manipulations of lifting, twirling, and thrusting are performed on all needles to reach de qi, which is a sensation typically associated with needling including soreness, numbness, swelling, heaviness, and other feelings. This is considered to be an important component of the therapeutic effect of acupuncture.
Intervention Type
Device
Intervention Name(s)
sham acupuncture
Intervention Description
The placebo needles chosen for this study are flat-tipped needles without a tip, which could not be pierced into the skin. In the meanwhile, an external patch device will fix the needles, which are visually pierced into the skin. After the treatment, the acupuncturist will press the acupuncture point with a dry cotton ball so that the patient can feel the pulling out of the "needle".
Primary Outcome Measure Information:
Title
The change in the mean number of CSBMs per week compared to baseline during the 8-week treatment period
Description
Complete Spontaneous Bowel Movements (CSBMs) refers to the frequency of a bowel movement that occurred in the absence of laxatives or manipulation.
Time Frame
At baseline, week 4 (in treatment), week 8 (end of treatment), and the follow-up period (week 12 and week 20 after randomization).
Secondary Outcome Measure Information:
Title
Bristol Stool Scale
Description
A scale to classify the patient's voluntary bowel movement stool.
Time Frame
At baseline and at week 8 (end of treatment).
Title
Patient Assessment of Constipation-Symptoms (PAC-SYM)
Description
A scale to assess the condition of the patient's constipation-related symptoms
Time Frame
At baseline and at week 8 (end of treatment).
Title
Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL)
Description
A brief but comprehensive assessment of the daily life quality of patients with FC, containing 28 items
Time Frame
At baseline and at week 8 (end of treatment).
Title
Self-rating Anxiety Scale(SAS)
Description
A measure of somatic symptoms associated with anxiety reactions.
Time Frame
At baseline and at week 8 (end of treatment).
Title
Self-rating Depression Scale(SDS)
Description
A self-rating scale to assess patients' depression
Time Frame
At baseline and at week 8 (end of treatment).
Title
Weekly usage of emergency bowel medications
Description
The proportions of participants using medications and doses for emergency treatment
Time Frame
At baseline and at week 8 (end of treatment).
Title
Incidence of adverse events
Description
The adverse events (AEs) assessment aims at evaluating the AEs of acupuncture treatment.
Time Frame
During 1-8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Meet Rome IV Diagnostic Criteria for Constipation and TCM Diagnostic Criteria of constipation with yin deficiency syndrome; No gender restriction, age 60-80; FC that is classified as mild or moderate; Have not used any medicine for constipation at least 2 weeks before treatment (except emergency treatment); Have not participated in other medical clinical trials over the past one month; Those who can understand various evaluation scales, complete the evaluation and cooperate with the completion of the planned course of treatment; Sign the informed consent. Exclusion Criteria: Irritable bowel syndrome and constipation caused by tumors, inflammatory reactions, endocrine and metabolic diseases, and drugs; Constipation caused by organic diseases; Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system, infectious diseases, tumors, and mental diseases; Those who voluntarily give up or cannot cooperate with treatment and observation due to various circumstances; Patients with cognitive impairment or aphasia; Those who take other drugs during treatment, which affect the efficacy and judgment (except emergency treatment).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
PING YIN
Phone
0086-18917561621
Email
bingxue616@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
YUELAI CHEN
Phone
0086-13020193726
Email
chenyuelai@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
PING YIN
Organizational Affiliation
Shanghai University of Traditional Chinese Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Longhua Hospital
City
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
PING YIN
Phone
0086-18917561621
Email
bingxue616@163.com

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21999154
Citation
Zhou K, Fang J, Wang X, Wang Y, Hong Y, Liu J, Wang L, Xue C, Wang P, Liu B, Zhu B. Characterization of de qi with electroacupuncture at acupoints with different properties. J Altern Complement Med. 2011 Nov;17(11):1007-13. doi: 10.1089/acm.2010.0652. Epub 2011 Oct 14.
Results Reference
background
PubMed Identifier
32111187
Citation
Dunstan DA, Scott N. Norms for Zung's Self-rating Anxiety Scale. BMC Psychiatry. 2020 Feb 28;20(1):90. doi: 10.1186/s12888-019-2427-6.
Results Reference
background
PubMed Identifier
31185948
Citation
Dunstan DA, Scott N. Clarification of the cut-off score for Zung's self-rating depression scale. BMC Psychiatry. 2019 Jun 11;19(1):177. doi: 10.1186/s12888-019-2161-0.
Results Reference
background

Learn more about this trial

Acupuncture for Functional Constipation in Older Adults

We'll reach out to this number within 24 hrs